Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung

Int J Tuberc Lung Dis. 2011 Feb;15(2):246-50, i.

Abstract

Objective: To characterise the prognosis and identify factors contributing to mortality in patients with tuberculous destroyed lung (TDL).

Design: Following a retrospective review of clinical data and radiographic findings, 169 patients with TDL were enrolled in this study. All patients were graded on a 4-point scale (field score 1-4) based on the extent of destroyed lung parenchyma on chest radiography.

Results: The mean patient age was 64 years (range 33-90); 103 (61%) were male. The median number of hospitalisations was 1 (range 0-11) during follow-up, with a mean duration of 31 months (range 0-172). Pneumonia developed in 96 patients (57%), while 50 patients (30%) developed acute respiratory failure requiring mechanical ventilation, 37 (22%) haemoptysis, 24 (14%) spontaneous pneumothorax and 22 (13%) reactivation of tuberculosis. Overall mortality was 28% (47/169), with a median survival of 39 months (range 0-176) after diagnosis. TDL-related mortality was 19% (32/169), and a field score ≥ 3 was the only independent predictor of shorter survival based on a Cox proportional hazards model (HR 3.520, 95%CI 1.51-8.20, P = 0.004).

Conclusion: TDL has a poor prognosis, particularly in patients with more extensive lung destruction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Hemoptysis / microbiology
  • Humans
  • Kaplan-Meier Estimate
  • Lung / microbiology
  • Lung / pathology*
  • Lung / physiopathology
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Pneumonia, Bacterial / microbiology
  • Pneumonia, Bacterial / mortality
  • Pneumothorax / microbiology
  • Proportional Hazards Models
  • Republic of Korea / epidemiology
  • Respiration, Artificial
  • Respiratory Insufficiency / microbiology
  • Respiratory Insufficiency / mortality
  • Respiratory System Agents / therapeutic use
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Survival Rate
  • Time Factors
  • Treatment Outcome
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / microbiology
  • Tuberculosis, Pulmonary / mortality*
  • Tuberculosis, Pulmonary / therapy

Substances

  • Respiratory System Agents